CD274 and neoplasm: The combination of ES@Cu(II)-MOF and programmed cell death-ligand 1 (PD-L1)-targeted therapy subsequently resulted in TME remodeling and increased T, B, and natural killer (NK) cell infiltration, thereby resulting in effective tumor ablation without obvious toxicity to normal tissues.